In another study enrolling 11 T-ALL patients with SET-NUP214 fusion, the LFS and OS at 3 years of SET-NUP214–positive patients were 45% and 73%, respectively (5), which is somehow consistent with the prognosis of patients with T-ALL in our center. Here, NUP214 is linked to acute lymphoblastic leukemia.